Exoskeleton Gloves Market
The market for Exoskeleton Gloves was estimated at $729 million in 2024; it is anticipated to increase to $1.53 billion by 2030, with projections indicating growth to around $2.85 billion by 2035.
Report Summary
Market Data
Methodology
Table of Contents
Global Exoskeleton Gloves Market Outlook
Revenue, 2024
$729M
Forecast, 2034
$2.52B
CAGR, 2025 - 2034
13.2%
The Exoskeleton Gloves industry revenue is expected to be around $825.6 million in 2025 and expected to showcase growth with 13.2% CAGR between 2025 and 2034. The market momentum indicates increasing investments in rehabilitation robotics and industrial ergonomics and worker augmentation technologies which demonstrates the growing strategic value of exoskeleton gloves in healthcare and manufacturing sectors. Organizations aim to measure productivity improvements and prevent musculoskeletal injuries while healthcare facilities and rehabilitation centers focus on accelerating functional recovery and achieving standardized treatment results. The development of soft robotics technology combined with lightweight materials and improved battery efficiency leads to better comfort and longer uptime which decreases ownership costs and speeds up market adoption. The growing need for safe high-quality manual tasks due to aging workforces and labor shortages drives relevance through regulatory support and clinical validation and enterprise pilot-to-scale transitions.
The assistive wearable robotics known as exoskeleton gloves enhance grip power while stabilizing hand movements to perform repetitive precise tasks through powered actuators or passive support systems. The typical features of these devices include soft exoskeleton architectures together with sensor fusion of EMG, IMU, force sensors, adaptive control algorithms, haptic feedback, modular sizing and cloud-enabled analytics for fleet management. The technology finds applications in stroke and neurorehabilitation as well as post-injury therapy, assembly, warehousing, field service and teleoperation in hazardous environments.
Market Key Insights
- The Exoskeleton Gloves market is projected to grow from $729.3 million in 2024 to $2.52 billion in 2034. This represents a CAGR of 13.2%, reflecting rising demand across Industrial assembly & logistics, VR/AR training & haptic simulation and Poststroke & neurorehabilitation.
- Bioservo Technologies, Roceso Technologies, Zunosaki are among the leading players in this market, shaping its competitive landscape.
- U.S. and China are the top markets within the Exoskeleton Gloves market and are expected to observe the growth CAGR of 11.9% to 15.8% between 2024 and 2030.
- Emerging markets including India, Vietnam and Mexico are expected to observe highest growth with CAGR ranging between 9.2% to 13.9%.
- Transition like From Therapy to Throughput is expected to add $96 million to the Exoskeleton Gloves market growth by 2030.
- The Exoskeleton Gloves market is set to add $1.8 billion between 2024 and 2034, with manufacturer targeting Rehabilitation Therapy & Assistive Living Applications projected to gain a larger market share.
- With Industrial ergonomics and injury prevention, and Expanding rehabilitation and assistive therapy demand., Exoskeleton Gloves market to expand 246% between 2024 and 2034.
Opportunities in the Exoskeleton Gloves
3PLs, parcel hubs, and e-commerce prioritize safety and throughput. The combination of ruggedized textiles with forcesensing actuators and AI grip assistance enables highfrequency picks and ergonomic lifting. The adoption risk decreases through partnerships with insurers and RaaS financing and OSHA-aligned analytics. The fastest growth of powered gripamplification gloves will also occur in sortation and case picking and last-mile load handling operations.
Growth Opportunities in North America and Asia Pacific
The exoskeleton glove market in North America benefits from strict ergonomics standards, high injury costs, and automation spend across automotive, aerospace, logistics, and e-commerce fulfillment. The market opportunities include industrial ergonomics programs, hand exoskeletons for force assistance, and rehabilitation deployments in clinics transitioning to home-based therapy. The buyers are looking for comfort, battery life, and seamless humanmachine interface with cobots and AMRs. The competitive field includes U. S. startups and European entrants partnering with OEMs and system integrators, with pilots scaling via ROI-backed safety cases. Defense and VA-driven research, ANSI/ISO guidance, and growing reimbursement discussions bolster medium-term adoption.
The Asia Pacific region experiences fast-growing demand for wearable robotics systems which are used in advanced manufacturing facilities across Japan, South Korea and China as well as for rehabilitation and eldercare services in aging populations. The market presents three main opportunities through soft-robotic exoskeleton gloves which enable precise assembly operations and warehouse picking and clinician-assisted recovery while requiring localized fit and language and service model adaptations. The market competition includes established robotics brands together with university spinoffs and cost-effective Chinese suppliers who create intense price competition that accelerates technological advancement. Government productivity programs together with smart factory investments enable trial operations while distributor networks and joint venture manufacturing facilities enhance market accessibility. The regulatory framework continues to evolve toward accepting lightweight compliant designs which require straightforward safety validation processes.
Market Dynamics and Supply Chain
01
Driver: Aging industrial workforce and stricter ergonomic mandates driving demand for strength-assist Exoskeleton Gloves
Manufacturers together with logistics providers encounter an aging workforce that extends their time in physically demanding positions which increases the risk of musculoskeletal disorders and productivity decline; employers test grip-augmentation and force-amplification exoskeleton gloves to delay fatigue and stabilize repetitive pick-and-place motions for sustaining throughput. OSHA along with EU-OSHA and insurers enforce stricter ergonomic mandates which drive organizations to adopt data-logging sensorized gloves that track force exposure for both EHS compliance and training purposes. The most anticipated application of exoskeleton gloves will also be in industrial material handling and warehouse operations including e-commerce fulfillment and automotive assembly line tasks because they reduce strain during high-frequency gripping and decrease lost-time injuries while providing return on investment through lower recordable rates and increased pick rates.
Soft robotics actuators provide lightweight backdrivable assistance through compliant mechanisms which feel natural and improve range of motion and support longer wear without pressure hotspots; newer textile exosuits and pneumatic micro-actuators also enable finer grip modulation and safer human-robot interaction. The advancement of clinical efficacy and patient adherence in post-stroke rehabilitation therapy will also benefit most from this application because therapists can also provide high-repetition task-specific training with embedded sensors for progress tracking and tele-rehab continuity which accelerates motor recovery while reducing clinic time and total cost of care.
02
Restraint: High Total Cost of Ownership and Unclear ROI
Exoskeleton gloves and hand exosuits require substantial capital expenditures and operational expenses because they need customized fitting and training and maintenance and battery replacements and firmware updates and integration with safety and IT workflows which results in high total cost of ownership but productivity gains and injury reduction benefits remain task-dependent and hard to quantify over short horizons which elongates procurement cycles and raises price sensitivity; manufacturers keep projects in pilot instead of scaling fleet deployments and SMBs opt for passive supports or simple grip aids and healthcare providers delay adoption pending reimbursement and clinical evidence which collectively slows market demand and pushes vendors toward leasing/OpEx models and compresses margins that limit channel expansion and after-sales support investments.
03
Opportunity: Germany and Italy stroke rehabilitation clinics will expand medical Exoskeleton Gloves across clinic-to-home therapy and Aging Japanese manufacturing workforce will accelerate industrial Exoskeleton Gloves adoption for ergonomic assisted assembly
Healthcare providers want to achieve quicker functional improvements while reducing therapy workloads because stroke cases are increasing with the aging population. The integration of VR gamification with haptics and telerehab dashboards happens through clinic-university partnerships. The healthcare payment system is testing reimbursement for remote monitoring services. Medical rehab gloves with softactuated technology and MDR compliance will experience the most rapid growth in Germany and Italy by transitioning from inpatient therapy to supervised home programs.
The aging workforce in Japan and small and medium-sized enterprises factories experience increasing musculoskeletal claims. The market potential remains unexplored in the sectors of electronics assembly and food processing. Soft robotics combined with low-profile batteries and sensor analytics allows for continuous wear throughout the day. The market will experience its most rapid expansion through semipowered industrial assist gloves which perform repetitive assembly and inspection work.
04
Challenge: Ergonomics, Usability, and Safety Limitations
The current hand exoskeletons present several limitations including bulkiness and weight addition and restricted fine motor control and tactile feedback and heat generation and actuator noise production and latency issues and limited all-day battery life and PPE compatibility and hygiene concerns for shared use and fit problems across different anthropometric measurements which leads to user rejection and decreased sustained usage; for instance, safety committees and unions stop deployments after users experience discomfort or fatigue thus buyers restrict use to brief tasks or rehabilitation sessions instead of manufacturing and logistics operations that span the entire shift and the requirement for regular adjustment and training leads to increased downtime which decreases actual return on investment and hinders repeat orders and ecosystem growth in industrial and healthcare sectors.
Supply Chain Landscape
1
Components
MaxonFaulhaberSTMicroelectronics
2
OEM Manufacturing
HaptXSenseGloveBioservo
3
Distribution & Integration
GraingerHenry ScheinTD SYNNEX
4
End Users
ManufacturingLogistics & WarehousingHealthcare & Rehabilitation
1
Components
MaxonFaulhaberSTMicroelectronics
2
OEM Manufacturing
HaptXSenseGloveBioservo
3
Distribution & Integration
GraingerHenry ScheinTD SYNNEX
4
End Users
ManufacturingLogistics & WarehousingHealthcare & Rehabilitation
Use Cases of Exoskeleton Gloves in Industrial assembly & logistics & VR/AR training & haptic simulation
Industrial assembly & logistics : The industrial sector uses powered soft exoskeleton gloves to enhance grip strength for tool handling and picking and repetitive fastening operations. The system provides sensor and actuator functionality through work gloves to enhance flexibility while maintaining dexterity and reducing muscle fatigue and musculoskeletal disorders and stabilizing production cycles. Bioservos Ironhand stands out through its validated ergonomic impact and analytics and OEM integrations while Ottobocks Paexo hand solutions focus on thumb-intensive tasks using their global EHS credibility and extensive service network.
Poststroke & neurorehabilitation : The soft robotic exoskeleton glove which operates through pneumatic or cabledriven systems functions in poststroke and neurorehabilitation to provide activeassisted range of motion and repetitive task practice. The application of graded assistance through sensorbased feedback by clinicians and home users promotes neuroplasticity while tracking progress and enabling personalized therapy. The Neofects RAPAEL Smart Glove combines game-based exercises with data analysis capabilities while the SaeboGlove delivers lightweight dynamic extension for daily activities and Gloreha offers clinic-grade robotic mobilization which leads to widespread clinical adoption and robust evidence bases.
VR/AR training & haptic simulation : The application of forcefeedback exoskeleton gloves in VR/AR training, simulation, and teleoperation enables realistic object interaction through kinesthetic resistance and tactile cues. The training system allows safe practice of complex procedures which shortens the time to competency and enhances knowledge retention and enables remote robotics control. HaptX stands out with its high-fidelity microfluidic actuation technology and enterprise-level deployments while SenseGlove provides cost-effective force feedback for industrial training and Manus delivers tight ecosystem integration and motion-capture workflows to boost adoption in manufacturing and defense programs.
Recent Developments
The development of Exoskeleton Gloves continues through advancements in lightweight soft-robotic structures and enhanced torque-to-weight actuation systems and AI-powered grip assistance. The validation process and scale-up of products are accelerated through OEM partnerships in automotive and logistics and targeted investments in rehab robotics. The acquisition of select tuck-in companies enables the consolidation of intellectual property related to haptics sensors and battery modules which enhances product development plans. These strategic moves reduce time-to-market while enabling new use cases and supporting regulatory compliance.
January 2024 : HaptX presented its G1 haptic gloves at CES 2024 to announce their general availability and first enterprise delivery.
November 2023 : HaptX introduced the G1 haptic gloves which use microfluidic force feedback technology and started accepting preorders for enterprise and research organizations.
June 2023 : Bioservo launched Carbonhand 2 with EU MDR CE marking, initiating European commercialization of its medical grip-assist exoskeleton glove.
Impact of Industry Transitions on the Exoskeleton Gloves Market
As a core segment of the Industrial Supplies industry,
the Exoskeleton Gloves market develops in line with broader industry shifts.
Over recent years, transitions such as From Therapy to Throughput and AI-Powered Personalization and Connected Ecosystems have redefined priorities
across the Industrial Supplies sector,
influencing how the Exoskeleton Gloves market evolves in terms of demand, applications and competitive dynamics.
These transitions highlight the structural changes shaping long-term growth opportunities.
01
From Therapy to Throughput
Exoskeleton gloves have evolved from specialized rehabilitation tools into industrial automation devices which boost production rates and minimize operational risks. The new designs combine high-torque actuators with lightweight composites and long battery life and sensor fusion to provide grip-strength augmentation and force assistance without compromising ergonomics or dexterity. Wearable robotics enable manufacturers and logistics operators to prevent musculoskeletal disorders while enhancing occupational safety KPIs. A Tier-1 automotive supplier achieved 18% faster task cycles and 35% fewer strain injuries and a 2.1x ROI during their first 12 months after implementing hand exoskeletons at torque and kitting stations.
02
AI-Powered Personalization and Connected Ecosystems
The upcoming wave combines edge AI with biomechanics analytics and haptic feedback to deliver adaptive assistance and quality control. Smart exoskeleton gloves acquire user intentions through real-time force profile adjustments which connect to MES systems and cobots and AR guidance for complete workflow integration. A healthcare stroke rehabilitation network achieved a 27% reduction in functional grasp time and a 22% increase in session adherence through machine-learning exoglove protocols which resulted in better payer outcomes and improved clinician productivity and clinic capacity.